586 related articles for article (PubMed ID: 15917521)
1. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
[TBL] [Abstract][Full Text] [Related]
5. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
[TBL] [Abstract][Full Text] [Related]
6. Is infection with hypermutable Pseudomonas aeruginosa clinically significant?
Auerbach A; Kerem E; Assous MV; Picard E; Bar-Meir M
J Cyst Fibros; 2015 May; 14(3):347-52. PubMed ID: 25308183
[TBL] [Abstract][Full Text] [Related]
7. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Hogardt M; Heesemann J
Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
10. Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
Rees VE; Yadav R; Rogers KE; Bulitta JB; Wirth V; Oliver A; Boyce JD; Peleg AY; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104278
[TBL] [Abstract][Full Text] [Related]
11. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
Oliver A; Cantón R; Campo P; Baquero F; Blázquez J
Science; 2000 May; 288(5469):1251-4. PubMed ID: 10818002
[TBL] [Abstract][Full Text] [Related]
12. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW
Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
[TBL] [Abstract][Full Text] [Related]
14. Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.
McCurtain JL; Gilbertsen AJ; Evert C; Williams BJ; Hunter RC
J Med Microbiol; 2019 Mar; 68(3):446-455. PubMed ID: 30688634
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
[TBL] [Abstract][Full Text] [Related]
16. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
17. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
Evans TJ
Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
[TBL] [Abstract][Full Text] [Related]
19. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection.
Darch SE; McNally A; Harrison F; Corander J; Barr HL; Paszkiewicz K; Holden S; Fogarty A; Crusz SA; Diggle SP
Sci Rep; 2015 Jan; 5():7649. PubMed ID: 25578031
[TBL] [Abstract][Full Text] [Related]
20. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.
Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
